CL2014002605A1 - Compounds derived from indole and indazole that activate ampk; pharmaceutical composition that includes them; and use to treat or prevent chronic kidney disease, diabetic nephropathy, diabetes, among other diseases. - Google Patents

Compounds derived from indole and indazole that activate ampk; pharmaceutical composition that includes them; and use to treat or prevent chronic kidney disease, diabetic nephropathy, diabetes, among other diseases.

Info

Publication number
CL2014002605A1
CL2014002605A1 CL2014002605A CL2014002605A CL2014002605A1 CL 2014002605 A1 CL2014002605 A1 CL 2014002605A1 CL 2014002605 A CL2014002605 A CL 2014002605A CL 2014002605 A CL2014002605 A CL 2014002605A CL 2014002605 A1 CL2014002605 A1 CL 2014002605A1
Authority
CL
Chile
Prior art keywords
indazole
indole
diabetes
diseases
treat
Prior art date
Application number
CL2014002605A
Other languages
Spanish (es)
Inventor
Kevin James Filipski
Esther Cheng Yin Lee
Samit Kumar Bharracharya
Kimberly O'keefe Cameron
Matthew Scott Dowling
David Christopher Ebner
Dilinie Pradadhini Fernando
Melhua Mike Tu
Daniel Wel-Shung Kung
Aaron Christopher Smith
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CL2014002605A1 publication Critical patent/CL2014002605A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G1/00—Production of liquid hydrocarbon mixtures from oil-shale, oil-sand, or non-melting solid carbonaceous or similar materials, e.g. wood, coal
    • C10G1/10—Production of liquid hydrocarbon mixtures from oil-shale, oil-sand, or non-melting solid carbonaceous or similar materials, e.g. wood, coal from rubber or rubber waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J8/00—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes
    • B01J8/08—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes with moving particles
    • B01J8/10—Chemical or physical processes in general, conducted in the presence of fluids and solid particles; Apparatus for such processes with moving particles moved by stirrers or by rotary drums or rotary receptacles or endless belts
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10B—DESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
    • C10B1/00—Retorts
    • C10B1/02—Stationary retorts
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10B—DESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
    • C10B47/00—Destructive distillation of solid carbonaceous materials with indirect heating, e.g. by external combustion
    • C10B47/02—Destructive distillation of solid carbonaceous materials with indirect heating, e.g. by external combustion with stationary charge
    • C10B47/06—Destructive distillation of solid carbonaceous materials with indirect heating, e.g. by external combustion with stationary charge in retorts
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10B—DESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
    • C10B47/00—Destructive distillation of solid carbonaceous materials with indirect heating, e.g. by external combustion
    • C10B47/28—Other processes
    • C10B47/32—Other processes in ovens with mechanical conveying means
    • C10B47/44—Other processes in ovens with mechanical conveying means with conveyor-screws
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10B—DESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
    • C10B53/00—Destructive distillation, specially adapted for particular solid raw materials or solid raw materials in special form
    • C10B53/07—Destructive distillation, specially adapted for particular solid raw materials or solid raw materials in special form of solid raw materials consisting of synthetic polymeric materials, e.g. tyres
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10B—DESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
    • C10B57/00—Other carbonising or coking processes; Features of destructive distillation processes in general
    • C10B57/04—Other carbonising or coking processes; Features of destructive distillation processes in general using charges of special composition
    • C10B57/06—Other carbonising or coking processes; Features of destructive distillation processes in general using charges of special composition containing additives
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10B—DESTRUCTIVE DISTILLATION OF CARBONACEOUS MATERIALS FOR PRODUCTION OF GAS, COKE, TAR, OR SIMILAR MATERIALS
    • C10B7/00—Coke ovens with mechanical conveying means for the raw material inside the oven
    • C10B7/10—Coke ovens with mechanical conveying means for the raw material inside the oven with conveyor-screws
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10K—PURIFYING OR MODIFYING THE CHEMICAL COMPOSITION OF COMBUSTIBLE GASES CONTAINING CARBON MONOXIDE
    • C10K1/00—Purifying combustible gases containing carbon monoxide
    • C10K1/001—Purifying combustible gases containing carbon monoxide working-up the condensates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2208/00—Processes carried out in the presence of solid particles; Reactors therefor
    • B01J2208/00008—Controlling the process
    • B01J2208/00017—Controlling the temperature
    • B01J2208/00389—Controlling the temperature using electric heating or cooling elements
    • B01J2208/00398—Controlling the temperature using electric heating or cooling elements inside the reactor bed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2208/00—Processes carried out in the presence of solid particles; Reactors therefor
    • B01J2208/00008—Controlling the process
    • B01J2208/00017—Controlling the temperature
    • B01J2208/00389—Controlling the temperature using electric heating or cooling elements
    • B01J2208/00407—Controlling the temperature using electric heating or cooling elements outside the reactor bed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2208/00—Processes carried out in the presence of solid particles; Reactors therefor
    • B01J2208/00008—Controlling the process
    • B01J2208/00017—Controlling the temperature
    • B01J2208/00389—Controlling the temperature using electric heating or cooling elements
    • B01J2208/00415—Controlling the temperature using electric heating or cooling elements electric resistance heaters
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2208/00—Processes carried out in the presence of solid particles; Reactors therefor
    • B01J2208/00008—Controlling the process
    • B01J2208/00017—Controlling the temperature
    • B01J2208/00504—Controlling the temperature by means of a burner
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2208/00—Processes carried out in the presence of solid particles; Reactors therefor
    • B01J2208/00008—Controlling the process
    • B01J2208/00539—Pressure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2208/00—Processes carried out in the presence of solid particles; Reactors therefor
    • B01J2208/00796—Details of the reactor or of the particulate material
    • B01J2208/00823—Mixing elements
    • B01J2208/00858—Moving elements
    • B01J2208/00876—Moving elements outside the bed, e.g. rotary mixer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00002—Chemical plants
    • B01J2219/00004—Scale aspects
    • B01J2219/00006—Large-scale industrial plants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/141—Feedstock
    • Y02P20/143—Feedstock the feedstock being recycled material, e.g. plastics
CL2014002605A 2012-04-10 2014-09-29 Compounds derived from indole and indazole that activate ampk; pharmaceutical composition that includes them; and use to treat or prevent chronic kidney disease, diabetic nephropathy, diabetes, among other diseases. CL2014002605A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261622149P 2012-04-10 2012-04-10

Publications (1)

Publication Number Publication Date
CL2014002605A1 true CL2014002605A1 (en) 2014-12-19

Family

ID=48193274

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002605A CL2014002605A1 (en) 2012-04-10 2014-09-29 Compounds derived from indole and indazole that activate ampk; pharmaceutical composition that includes them; and use to treat or prevent chronic kidney disease, diabetic nephropathy, diabetes, among other diseases.

Country Status (5)

Country Link
EP (1) EP2836571A1 (en)
JP (1) JP2015518510A (en)
CA (1) CA2870183A1 (en)
CL (1) CL2014002605A1 (en)
WO (1) WO2013155238A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017371717B2 (en) * 2016-12-09 2022-10-06 Keshi Technologies Pty Ltd Process for the thermal degradation of rubber containing waste
WO2018102883A1 (en) 2016-12-09 2018-06-14 Keshi Technologies Pty Ltd Hermetically sealed flow-through reactor for non-oxidative thermal degradation of a rubber containing waste
CN108913221B (en) * 2018-06-27 2020-10-09 陕西延长石油（集团）有限责任公司 Oil-containing and dust-containing gas quenching device and method
CN112080295B (en) * 2020-06-12 2021-09-14 广州环渝能源科技有限公司 Sealed carbon discharging method
CN112080301B (en) * 2020-10-08 2021-12-17 杨松 Process method for preparing lemon essential oil by pyrolysis of waste tires
CN114231302B (en) * 2021-11-16 2022-08-12 四川轻化工大学 Small-size independent modular skid-mounted pyrolysis device of function

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235676A (en) * 1977-09-16 1980-11-25 Deco Industries, Inc. Apparatus for obtaining hydrocarbons from rubber tires and from industrial and residential waste
US5208401A (en) * 1989-06-28 1993-05-04 Universite Laval Separation of commercially valuable chemicals from tire-derived pyrolytic oils
AU8119801A (en) * 2000-08-10 2002-02-25 Rj Leegroup Inc Low energy method of pyrolysis of hydrocarbon materials such as rubber

Also Published As

Publication number Publication date
JP2015518510A (en) 2015-07-02
CA2870183A1 (en) 2013-10-17
EP2836571A1 (en) 2015-02-18
WO2013155238A1 (en) 2013-10-17

Similar Documents

Publication Publication Date Title
CL2014002605A1 (en) Compounds derived from indole and indazole that activate ampk; pharmaceutical composition that includes them; and use to treat or prevent chronic kidney disease, diabetic nephropathy, diabetes, among other diseases.
CO7091185A2 (en) Indole and indazole compounds that activate ampk
CL2014001988A1 (en) A 5- (4-cyclopropyl-1h-imidazol-1-yl) -n- (6- (4-isopropyl-4h-1,2,4-triazol-3-yl) pyridin-2-yl) -2 compound -fluoro-4-methylbenzamide or its salts, as inhibitors of the apoptosis signal regulatory kinase; intermediary compounds; pharmaceutical composition; and its use for the treatment of chronic kidney disease, diabetic nephropathy, renal fibrosis, among others.
CL2008001099A1 (en) COMPOUNDS DERIVED FROM INDAZOL; AND ITS USE TO TREAT DISEASES MEDIATED BY S1P1 RECEPTORS, SUCH AS MULTIPLE SCLEROSIS, AUTOIMMUNE DISEASE, INFLAMMATORY DISORDERS, DIABETES, BETWEEN OTHER.
PH12015502275B1 (en) Therapuetic uses of empagliflozin
CL2011002989A1 (en) Neutral endopeptidase (nep) inhibitor heterocyclic compounds; pharmaceutical composition; pharmaceutical combination; use of the compound to treat a disorder or disease such as hypertension, heart failure, kidney failure, epilepsy, metabolic syndrome, among others.
CL2015003022A1 (en) Use of empagliflozin in the preparation of a useful medication in the treatment of chronic kidney disease
CL2014000490A1 (en) Compounds derived from pyrazole and its salts, with sglt1 inhibitory activity; pharmaceutical composition that includes them; and its use to treat or prevent diabetes.
CL2013002053A1 (en) Heterocyclic derivative compounds, glucagon receptor antagonists; pharmaceutical composition that includes it and its use in the treatment of diabetes and metabolic diseases. pct
CL2015001160A1 (en) Thiophene fused tricyclic derivative compounds, janus kinase inhibitors (jak); pharmaceutical composition that includes them; method to inhibit the activity of jak1; method to treat an autoimmune disease, a cancer, a myeloproliferative disorder and an inflammatory disease, among other diseases.
MX2020010004A (en) Therapeutic uses of empagliflozin.
CL2015002546A1 (en) Substituted 3-phenylpropylamine derivatives for the treatment of diseases and ophthalmic disorders
CL2009000048A1 (en) Use of compounds derived from triterpenoids in the treatment of kidney failure, and associated diseases such as: nephropathies, insulin resistance, diabetes, vascular pathologies, among others.
CL2015001279A1 (en) Compounds derived from pyridine, urate transporter inhibitors urat 1; pharmaceutical composition that includes them; use for the treatment or prevention of diseases such as gout, hyperuricemia, hypertension, kidney diseases, among others.
CL2008002076A1 (en) Compounds derived from substituted aryloxazoles; process for preparing said compounds; pharmaceutical composition comprising them; and its use to treat diabetes, metabolic syndrome, dyslipidemias, among other diseases.
MX2019005748A (en) Biomarkers related to kidney function and methods using the same.
CL2012002189A1 (en) Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
EA201490420A1 (en) TREATMENT OF DISEASES ASSOCIATED WITH α-SUBUNITS OF POTENTIAL-DEPENDENT SODIUM CHANNELS (SCNxA) WITH THE HELP OF SMALL MOLECULES
CL2008001815A1 (en) Indazole derived compounds; process for preparing said compounds; pharmaceutical composition comprising them; and its use to treat cancer.
CL2014003031A1 (en) Compounds derived from bicyclic substituted uracil; preparation procedure; pharmaceutical composition; use to treat and / or prevent heart failure, pulmonary hypertension, epoc, asthma, nephropathy, among others.
CL2008000593A1 (en) USE OF COMPOUNDS DERIVED FROM REPLACED HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND OTHER ACTIVE AGENTS; AND ITS USE TO TREAT DIABETES, ATEROSCLEROTIC DISEASE OF ARTERIES BETWEEN OTHER DISEASES.
BRPI0813680A2 (en) IRNA AGENTS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME, AS WELL AS USE.
UY32464A (en) NEW INDAZOL COMPOUNDS
CL2014001828A1 (en) Dual-release oral dosage system comprising doxylamine and pyridoxine and / or its analogs, metabolites and salts thereof; oral dosage form dual release; pharmaceutical kit; use to relieve symptoms of nausea and vomiting, including those of pregnancy.
CL2013003143A1 (en) Use of compounds derived from phenylaminopyrimidinyl, an enantiomer or a pharmaceutically acceptable salt thereof to reduce the viability of multiple myeloma cells in a state of non-responsive cells to il-6 and / or having a cd45- phenotype.